Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹852 Cr₹1,097 Cr₹747 Cr₹768 Cr₹704 Cr

What is the latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS is ₹852 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹852 Cr
Mar2024₹1,097 Cr
Mar2023₹747 Cr
Mar2022₹768 Cr
Mar2021₹704 Cr

How is Cash Flow from Operating Activities of EMCURE PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹852 Cr
-22.38
Mar2024 ₹1,097 Cr
46.92
Mar2023 ₹747 Cr
-2.78
Mar2022 ₹768 Cr
9.05
Mar2021 ₹704 Cr -

Compare Cash Flow from Operating Activities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,880.7 Cr -1.8% -5% 33.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,062.0 Cr 0.4% 2.6% NA Stock Analytics
DIVIS LABORATORIES ₹164,192.0 Cr -4.5% 0.7% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,129.0 Cr 5% 4.1% 37.2% Stock Analytics
CIPLA ₹108,513.0 Cr -0.5% -3.4% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,250.0 Cr 1.2% 10.2% 4.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-1.8%

-5%

33.4%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses